Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "SUIT-026 AmR mt D064"

From Bioblast
Line 6: Line 6:
|SUIT number=D064_1S;2Rot;3D;4Ama
|SUIT number=D064_1S;2Rot;3D;4Ama
}}
}}
::: '''[[MitoPedia: SUIT]]''' - Protocol for Evaluation of ROS production by RET in isolated mitochondria
::: '''[[MitoPedia: SUIT]]''' - Protocol for the evaluation of ROS production by RET in mtprep
::: '''[[SUIT protocol pattern]]:'''  1S;2Rot;3D;4Ama
::: '''[[SUIT protocol pattern]]:'''  1S;2Rot;3D;4Ama


SUIT-026 AmR mt D064 has been designed to study the [[Reverse_electron_flow_from_CII_to_CI| RET]]-initiated ROS production in isolated mitochondria. The protocol is focused on [[LEAK]] state for the [[S-pathway]] to provide the conditions of high membrane potential and redox power in the Q-junction. Under these conditions, in several samples has been described that a reverse flow of the electrons into the membrane arm and the quinone binding site of the Complex I occurs, promoting the production of ROS. The addition of [[rotenone]] provides excellent control to this mechanism because this compound blocks the point on which the electrons leak from the Complex I leading to decreased ROS production. If rotenone would have been added before S titration, it had inhibited the RET. The titration of ADP at saturating concentrations to reach [[OXPHOS]] allows us to harmonize this protocol with [[ SUIT-006 O2 mt D022]] for quality control and a full assessment of the coupling control. Addition of [[Antimycin A|Ama]] leads to increased ROS production via inhibition of Complex III at the Qi site.
SUIT-026 AmR mt D064 has been designed to study the [[Reverse_electron_flow_from_CII_to_CI| RET]]-initiated ROS production in [[Mitochondrial preparations| mitochondrial preparations ([[Isolated mitochondria|isolated mitochondria]] and [[Tissue homogenate|tissue homogenate]] and [[Permeabilized cells|permeabilized cells]] which are already permeabilized when they are added to the chamber)]]. The protocol is focused on [[LEAK]] state for the [[S-pathway]] to provide the conditions of high membrane potential and redox power in the Q-junction. Under these conditions, in several samples has been described that a reverse flow of the electrons into the membrane arm and the quinone binding site of the Complex I occurs, promoting the production of ROS. The addition of [[rotenone]] provides excellent control to this mechanism because this compound blocks the point on which the electrons leak from the Complex I leading to decreased ROS production. If rotenone would have been added before S titration, it had inhibited the RET. The titration of ADP at saturating concentrations to reach [[OXPHOS]] allows us to harmonize this protocol with [[ SUIT-006 O2 mt D022]] for quality control and a full assessment of the coupling control. Addition of [[Antimycin A|Ama]] leads to increased ROS production via inhibition of Complex III at the Qi site.




Line 22: Line 22:
:::+ Short protocol.
:::+ Short protocol.
:::+ Rotenone provides an excellent control step for RET.
:::+ Rotenone provides an excellent control step for RET.
:::- The protocol does not allow to obtain all the coupling states of the sample. However, doing a DLPU to add an uncoupler will resolve this limitation.
:::- This protocol does not provide information about all the coupling control states (LEAK, OXPHOS and ET). However, it is possible to create a [[Export DL-Protocol User (*.DLPU)|DLPU]] by additing an Event&Mark for the uncoupler titration (4U) after ADP (3D) to obtain ET-state.
:::-  The addition of cytochrome ''c'' cannot be done in this SUIT protocol.


== Compare SUIT protocols ==
== Compare SUIT protocols ==
::::* [[SUIT-026 O2 mt D063]]: Respiratory control protocol.
::::* [[SUIT-006 O2 mt D022]]: CCP mtprep for S-pathway.
::::* [[SUIT-006 O2 mt D022]]: CCP mtprep for S-pathway.
::::* [[SUIT-026 O2 mt D063]]: Respiratory control protocol..





Revision as of 14:33, 26 June 2019


high-resolution terminology - matching measurements at high-resolution


SUIT-026 AmR mt D064

Description

SUIT-026 AmR mt D064.png

Abbreviation: RET

Reference: A - SUIT-026

SUIT number: D064_1S;2Rot;3D;4Ama

O2k-Application: AmR

MitoPedia: SUIT - Protocol for the evaluation of ROS production by RET in mtprep
SUIT protocol pattern: 1S;2Rot;3D;4Ama

SUIT-026 AmR mt D064 has been designed to study the RET-initiated ROS production in [[Mitochondrial preparations| mitochondrial preparations (isolated mitochondria and tissue homogenate and permeabilized cells which are already permeabilized when they are added to the chamber)]]. The protocol is focused on LEAK state for the S-pathway to provide the conditions of high membrane potential and redox power in the Q-junction. Under these conditions, in several samples has been described that a reverse flow of the electrons into the membrane arm and the quinone binding site of the Complex I occurs, promoting the production of ROS. The addition of rotenone provides excellent control to this mechanism because this compound blocks the point on which the electrons leak from the Complex I leading to decreased ROS production. If rotenone would have been added before S titration, it had inhibited the RET. The titration of ADP at saturating concentrations to reach OXPHOS allows us to harmonize this protocol with SUIT-006 O2 mt D022 for quality control and a full assessment of the coupling control. Addition of Ama leads to increased ROS production via inhibition of Complex III at the Qi site.


Communicated by Komlodi T, Iglesias-Gonzalez J and Gnaiger E (last update 2019-06-26)
MitoPedia: SUIT

Steps and respiratory states

SUIT-026 AmR mt D064.png


Step State Pathway Q-junction Comment - Events (E) and Marks (M)
0DTPA
  • DTPA is an iron chelator, which decreases the chemical fluorescence background created by the Amplex UltraRed assay. Administration of DTPA into the O2k-chamber is recommended before all other chemicals because the iron chelation capacity of the compound is time-dependent (approx. 10-15 min). However, the experiments can be carried out in the absence of DTPA.
0SOD
  • SOD or superoxide dismutase converts the anion superoxide released by the mitochondria into H2O2, making it accessible to the Amplex UltraRed assay.
0HRP
  • HRP or horseradish peroxidase catalyses the conversion of Amplex UltraRed and H2O2 towards the fluorescent resorufin.
0AmR
Step State Pathway Q-junction Comment - Events (E) and Marks (M)
1S SL(n) S CII 1S
2Rot SL(n) S CII 1S;2Rot
3D SP S CII 1S;2Rot;3D
4Ama ROX 1S;2Rot;3D;4Ama
  • Rox is the residual oxygen consumption in the ROX state, due to oxidative side reactions, estimated after addition of antimycin A (inhibitor of CIII). Rox is subtracted from oxygen flux as a baseline for all respiratory states, to obtain mitochondrial respiration (mt).


Questions.jpg


Click to expand or collaps

Strengths and limitations

  • The conditions on which RET is observable in isolated mitochondria are not physiological but it has been suggested that corresponds to some pathological states.
+ This protocol must be run parallel with SUIT-026 O2 mt D063 to have a respiratory control.
+ Short protocol.
+ Rotenone provides an excellent control step for RET.
- This protocol does not provide information about all the coupling control states (LEAK, OXPHOS and ET). However, it is possible to create a DLPU by additing an Event&Mark for the uncoupler titration (4U) after ADP (3D) to obtain ET-state.
- The addition of cytochrome c cannot be done in this SUIT protocol.

Compare SUIT protocols


References

MitoPedia concepts: SUIT protocol, SUIT A, Find 


MitoPedia methods: Fluorometry